Abstract:
The global incidence of Helicobacter pylori (H. pylori) infection is more than 50% of the world’s population. Prevalence can vary greatly between and within countries, depending on geographic location, ethnicity, age and socioeconomic factors: it is high in developing countries and lower in developed countries. The aim of the research was to analyze the international recommendations for the eradication of H. pylori in order to optimize the pharmaceutical supply.
